Katalin Karikó

Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Katalin Karikó, Michael Buckstein, Houping Ni et al. · Immunity · 2005 · 2.6K citations · Full text

Life Sciences, Immunology, Molecular Biology +16

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

Uğur Şahin, Alexander Muik, Evelyna Derhovanessian et al. · Nature · 2020 · 2K citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Katalin Karikó, Hiromi Muramatsu, Frank A. Welsh et al. · Molecular Therapy · 2008 · 1.9K citations · Full text

Life Sciences, Immunology, Molecular Biology +17

mRNA Is an Endogenous Ligand for Toll-like Receptor 3

Katalin Karikó, Houping Ni, John Capodici et al. · Journal of Biological Chemistry · 2004 · 1K citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes

Norbert Pardi, Steven Tuyishime, Hiromi Muramatsu et al. · Journal of Controlled Release · 2015 · 1K citations

Pharmacy, Molecular Biology, Molecular Pharmaceutics +17